Spinal Implant Market Research Report Forecast to 2030

The spinal Implant Market is projected to register a CAGR of 4.9% during the review period. The variables adding to the development of the market are the developing interest in negligibly intrusive spine medical procedures and the rising maturing demography.

The interest in negligibly obtrusive spine medical procedure is becoming attributable to the mechanical progression in the negligibly intrusive spine (MIS) and the rising inclination for negligibly obtrusive systems is ready to demonstrate favorable for market development. For example, in September 2021, Medtronic plc sent off Impetus PL and PL40, Space-D Access Framework, speed up join conveyance framework with Grafton DBF to its most recent augmentations to its negligibly obtrusive spine medical procedure biological system with cutting edge spinal advancements. This item helps the specialists eliminate changeability in the surgery, smooth out and customize care, and empower a better understanding of results.

In this manner, the popularity of negligibly obtrusive spine medical procedures and the rising geriatric populace are driving the development of the market.

Market Segment

The Spinal Implant Market has been segmented into spinal fusion devices, non-fusion devices, spine biologics, and others based on product type. The market for spinal implants has been divided into categories based on material, including ceramic, polymeric, metallic, and others.

The Spinal Implant Market has been divided into minimally invasive surgery and open surgery based on the procedure. The Spinal Implant Market has been divided into hospitals, orthopedic facilities, and other groups based on end users.

Regional Insights

North America represented the biggest market portion of 36.23% in 2022 attributable to the created medical care foundation, expanding spinal line injury cases, and the presence of many market players in the region. As per the Public Spinal Rope Injury Measurable Center, an expected 296,000 individuals in the US experienced spinal string wounds in 2020.

Europe is expected to observe huge development during the gauge time frame because of expanding pervasiveness and resulting expansion in the therapy paces of degenerative spine problems, progressions in clinical innovation, a quickly developing older populace, and expanding interest for negligibly obtrusive systems. Moreover, the German spinal implant market held the biggest market share in 2022 and France spinal implant market is the quickest developing market in the Europe region.

Asia-Pacific is expected to enlist the most noteworthy development rate over the figure period. This is because of elements like further developing medical care foundation, developing geriatric populace, and developing stationary life and changing way of life designs. Also, China spinal implant market held the biggest market share in 2022 and India spinal implant market is the quickest developing market in the Asia-Pacific region.

Major Players

Key Companies in the Spinal Implant Market include Medtronic Plc (Ireland), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Braun Melsungen AG (Germany), Nuvasive, Inc. (US), Zimmer Biomet Holdings Inc. (US), Orthofix Medical Inc. (US), Globus Medical (US), Alphatec (US), and Ulrich Medical (Germany).

Product Code: MRFR/MED/1518-CR

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.3. RESEARCH OBJECTIVE
2.4. ASSUMPTIONS
2.5. LIMITATIONS

3. RESEARCH METHODOLOGY

3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
- 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING TECHNIQUE
3.6. MARKET SIZE ESTIMATION
- 3.6.1. BOTTOM-UP APPROACH
- 3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION

4. MARKET DYNAMICS

4.1. OVERVIEW
4.2. DRIVERS
- 4.2.1. GROWING DEMAND FOR MINIMALLY INVASIVE SPINE SURGERY
- 4.2.2. RISING AGEING DEMOGRAPHY
- 4.2.3. INCREASING PREVALENCE OF SPINAL DISORDERS
4.3. RESTRAINTS
- 4.3.1. SIDE EFFECTS ASSOCIATED WITH THE SPINAL IMPLANT
- 4.3.2. HIGH COST OF SPINE TREATMENT
4.4. OPPORTUNITIES
- 4.4.1. GROWING DEMAND FOR SPINAL IMPLANTS

5. MARKET FACTOR ANALYSIS

5.1. VALUE CHAIN ANALYSIS
- 5.1.1. R&D
- 5.1.2. MANUFACTURING
- 5.1.3. DISTRIBUTION AND SALES
- 5.1.4. POST-SALES MONITORING
5.2. PORTER'S FIVE FORCES ANALYSIS
- 5.2.1. BARGAINING POWER OF SUPPLIERS
- 5.2.2. BARGAINING POWER OF BUYERS
- 5.2.3. THREAT OF NEW ENTRANTS
- 5.2.4. THREAT OF SUBSTITUTES
- 5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
- 5.3.1. IMPACT ON SUPPLY CHAIN
- 5.3.2. IMPACT ON PRODUCT TYPEION
- 5.3.3. IMPACT ON REGIONS
- 5.3.4. DEMAND-SUPPLY GAP ANALYSIS
- 5.3.5. IMPACT ON PRICING

6. GLOBAL SPINAL IMPLANT MARKET, BY PRODUCT TYPE

6.1. OVERVIEW
6.2. SPINAL FUSION DEVICES
- 6.2.1. THORACIC FUSION & LUMBAR FUSION DEVICES
- 6.2.2. CERVICAL FUSION DEVICES
- 6.2.3. EXPANDABLE FUSION CAGES
- 6.2.4. OTHERS
6.3. NON-FUSION DEVICES
- 6.3.1. DYNAMIC STABILIZATION DEVICES
- 6.3.2. ARTIFICIAL DISCS
- 6.3.3. ANNULUS REPAIR DEVICES
- 6.3.4. NUCLEAR DISC PROSTHESES
- 6.3.5. OTHERS
6.4. SPINE BIOLOGICS
6.5. OTHERS

7. GLOBAL SPINAL IMPLANT MARKET, BY MATERIAL

7.1. OVERVIEW
7.2. METALLIC MATERIAL
7.3. POLYMERS MATERIAL
7.4. CERAMIC MATERIAL
7.5. OTHERS

8. GLOBAL SPINAL IMPLANT MARKET, BY PROCEDURE

8.1. OVERVIEW
8.2. OPEN SURGERY
8.3. MINIMALLY INVASIVE SURGERY

9. GLOBAL SPINAL IMPLANT MARKET, BY END USER

9.1. OVERVIEW
9.2. HOSPITALS
9.3. ORTHOPEDIC CENTERS
9.4. OTHERS

10. GLOBAL SPINAL IMPLANT MARKET, BY REGION

10.1. OVERVIEW
10.1. NORTH AMERICA
- 10.1.1. US
- 10.1.2. CANADA
10.2. EUROPE
- 10.2.1. GERMANY
- 10.2.2. FRANCE
- 10.2.3. UK
- 10.2.4. ITALY
- 10.2.5. SPAIN
- 10.2.6. REST OF EUROPE
10.3. ASIA-PACIFIC
- 10.3.1. JAPAN
- 10.3.2. CHINA
- 10.3.3. INDIA
- 10.3.4. AUSTRALIA
- 10.3.5. SOUTH KOREA
- 10.3.6. REST OF ASIA-PACIFIC
10.4. REST OF THE WORLD
- 10.4.1. MIDDLE EAST
- 10.4.2. AFRICA
- 10.4.3. LATIN AMERICA

11. COMPANY LANDSCAPE

11.1. OVERVIEW
11.2. COMPETITIVE ANALYSIS
11.3. MARKET SHARE ANALYSIS
11.4. MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL IMPLANT MARKET
11.5. COMPETITIVE BENCHMARKING
11.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL IMPLANT MARKET
11.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
- 11.7.1. PRODUCT APPROVALS AND PRODUCT LAUNCHES
- 11.7.2. PARTNERSHIP/COLLABORATION
- 11.7.3. EXPANSIONS/AGREEMENT
- 11.7.4. MERGERS & ACQUISITIONS
11.8. MAJOR PLAYERS FINANCIAL MATRIX
- 11.8.1. SALES & OPERATING INCOME, 2022
- 11.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2022

12. COMPANY PROFILES

12.1. MEDTRONIC PLC
- 12.1.1. COMPANY OVERVIEW
- 12.1.2. FINANCIAL OVERVIEW
- 12.1.3. PRODUCTS OFFERED
- 12.1.4. KEY DEVELOPMENTS
- 12.1.5. SWOT ANALYSIS
- 12.1.6. KEY STRATEGIES
12.2. JOHNSON & JOHNSON SERVICES, INC.
- 12.2.1. COMPANY OVERVIEW
- 12.2.2. FINANCIAL OVERVIEW
- 12.2.3. PRODUCTS OFFERED
- 12.2.4. KEY DEVELOPMENTS
- 12.2.5. SWOT ANALYSIS
- 12.2.6. KEY STRATEGIES
12.3. STRYKER CORPORATION
- 12.3.1. COMPANY OVERVIEW
- 12.3.2. FINANCIAL OVERVIEW
- 12.3.3. PRODUCTS OFFERED
- 12.3.4. KEY DEVELOPMENTS
- 12.3.5. SWOT ANALYSIS
- 12.3.6. KEY STRATEGIES
12.4. B. BRAUN MELSUNGEN AG
- 12.4.1. COMPANY OVERVIEW
- 12.4.2. FINANCIAL OVERVIEW
- 12.4.3. PRODUCTS OFFERED
- 12.4.4. KEY DEVELOPMENTS
- 12.4.5. SWOT ANALYSIS
- 12.4.6. KEY STRATEGIES
12.5. NUVASIVE, INC.
- 12.5.1. COMPANY OVERVIEW
- 12.5.2. FINANCIAL OVERVIEW
- 12.5.3. PRODUCTS OFFERED
- 12.5.4. KEY DEVELOPMENTS
- 12.5.5. SWOT ANALYSIS
- 12.5.6. KEY STRATEGIES
12.6. ZIMMER BIOMET HOLDINGS INC.
- 12.6.1. COMPANY OVERVIEW
- 12.6.2. FINANCIAL OVERVIEW
- 12.6.3. PRODUCTS OFFERED
- 12.6.4. KEY DEVELOPMENTS
- 12.6.5. SWOT ANALYSIS
- 12.6.6. KEY STRATEGIES
12.7. ORTHOFIX MEDICAL INC.
- 12.7.1. COMPANY OVERVIEW
- 12.7.2. FINANCIAL OVERVIEW
- 12.7.3. PRODUCTS OFFERED
- 12.7.4. KEY DEVELOPMENTS
- 12.7.5. SWOT ANALYSIS
- 12.7.6. KEY STRATEGIES
12.8. GLOBUS MEDICAL
- 12.8.1. COMPANY OVERVIEW
- 12.8.2. FINANCIAL OVERVIEW
- 12.8.3. PRODUCTS OFFERED
- 12.8.4. KEY DEVELOPMENTS
- 12.8.5. SWOT ANALYSIS
12.9. ALPHATEC
- 12.9.1. COMPANY OVERVIEW
- 12.9.2. FINANCIAL OVERVIEW
- 12.9.3. PRODUCTS OFFERED
- 12.9.4. KEY DEVELOPMENTS
- 12.9.5. SWOT ANALYSIS
- 12.9.6. KEY STRATEGIES
12.10. ULRICH MEDICAL
- 12.10.1. COMPANY OVERVIEW
- 12.10.2. FINANCIAL OVERVIEW
- 12.10.3. PRODUCTS OFFERED
- 12.10.4. KEY DEVELOPMENTS
- 12.10.5. SWOT ANALYSIS
- 12.10.6. KEY STRATEGIES

13. APPENDIX

13.1. REFERENCES
13.2. RELATED REPORTS